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Abstract Primer extension arrest (PEA) studies have demon- 
strated that antismme oilgenucleetides (Jlll2C, Jlll4C), which lie 
upstremn of a ribozyme targeted m ~amyloid peptide precursor 
(JtAPP) mRNA, but not sense oligenucleetides (Jill2S, plI6S) 
or st scrambled ollgonucleotlde, J3116M, affect ribozyme- 
mediated cleavage in vitro. Substrate dissociation expeflments 
revealed that the flbozyme binding site in this mRNA was 
masked; PEA kinetics showed the association of the ribozyme 
and substrate waq enhanced by antiseuse oligonucleotide binding. 
These studies uggest hat masked bozyme cleavage sites that 
may occur in disease-causing mRNAs can he targeted for 
delgradatio.q using "fa©itJtator" ollgonudeotides. 
Key wor~lv: Ribozyme; Facilitator oligonucleotide; [3APP 
mRNA 
1. Introduction 
Catalytic RNAs have been found in a large number of 
diverse organisms. Examples have been found in plants, ani- 
mals, eubacteria, viruses and fungi [1-5]. Minimal catalytic 
motifs have been deduced for each of the seven types of 
known catalytic RNA, and trans.cleaving variants based on 
these motifs have been constructed [6~8]. Such molecules may 
potentially be useful therapeutically as antiviral agents or in 
attenuating or repairing mutant cellular messages that cause 
genetic diseases [9,10]. 
Subtle primary, secondary and tertiary structure interac- 
tions oftt, n lead to large differences in the cleavage rates of 
a particular catalytic motif [2,11-13]. In particular, we and 
others have shown that the hammerhead ribozyme cleavage 
rate is often substantially ess for full-length substrate RNAs 
than for shorter substrates [14-16]. In order to generate ribo- 
zymes for therapeutic applications it is essential that they 
cleave full-length messages well. Several methods have been 
devised to improve ribozyme lticiencies. One such strategy, 
oligonucleotide-mediated or facilitated ribozyme cleavage, has 
been shown to enhance ribozyme catalysis and promote ribo- 
zyme cleavage at lower concentrations of magnesium in vitro 
[15-17]. The studies presented in this paper address how oli- 
gonucleotides facilitate ribozyme-mediated degradation of 
fullqength messages in vitro. 
*Fax: (I) (718) 494-5287. 
Abbreviations: I3APP, Alzheimer amyloid peptide precursor; 6APP6~ 
or BAPPr~t, alternatively spliced variants of [3APP mRNA; PEA, 
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2. Materials and methods \ 
2. !. Synthesis of oRgonucleotides '~ 
Sense, antisense and scrambled oligodeoxynucleotihes w re synthe- 
sized by cyanoethyl phosphoramidite chemistry on ~n Applied Bio. 
systems 380B DNA synhlesizer [18]. Following cle~lvage from the 
solid support, samples were ethanol precipitated, w~,~;hed with 70% 
ethanol and resuspended in sterile water. Aliquots wc~e labeled with 
['~ P]ATP [19] and r,.solved on deI: raring polyacry[amide gels to 
check for homogeneity. 
Substrate dissociation kineticv 
2'2Ribozyme- cleavage reactions were performed as tlescribed pre- 
t 
viously [20-22]. Substrate dissociation rates were measlured by parti- 
tioning experiments [23] with minor modifications. BI]iefly, separate 
solutions of ribozyme core RNA, a2P-radiolabeled st[bstrate RNA 
and unlabeled substrata RNA were heat denatured] at 95°C for 
I min and then preincubated at 37°C in 10 mM MgCI:]. In a typical 
experiment, two identical reaction mixtures were prepaded containing ~2 • P-radiolabeled substrata RNA and a fifteen-fold exces~ of ribozyme 
core RNA. This ensured 10-20% substrate cleavage ocel[rred. Follow- 
ing this, a ten-fold excess of unlabeled substrate RNA ~ver ibozyme 
core RNA was added to one of the reaction mixtures mid the incuba- 
tion was continued. At the indicated times, 5-pl aliquots were with- 
drawn and the reaction stopped by adding 2.5 pl of 10 M urea. The 
resulting mixtures were quick frozen on dry-ice until they were used. 
RNA cleavage products were separated from unreac~.ed substrata 
RNA by electrophoresis through 10% polyacrylamide/7M urea gels. 
Detection by autoradiography and quantification by sumning densi- 
tometry were performed as previously described [19]. No 32P-radiola- 
baled substrata cleavage was detected in control reactions in wi~ich it
was pre-diluted with the same xcess of unlabeled substrata RNA that 
was used in the chase reaction. Values for k-t were determined from 
the difference between the slopes of ln(FracS*) versus time plots of 
cleavage in the presence or absence of competitor substrata RNA [24]. 
2. 3. Primer extension arrest 
Ribozyme cleavage reactions with full.length RNA substrates were 
performed as described previously [15]. Briefly, 100 nM of J3APPe95 or 
[3APP75t mRNA and 400 nM of active or inactive ribozyme core 
RNAs were separately heat denatured at 95eC for 1 rain and then 
preincubated at37ec in 10 mM MgCI~ for 5 min. Reacticns, in a total 
volume of 12 pl, were initiated by combining the subst:ate, core ri- 
bozyme RNA solutions and, where appropriate, facilit~tor oligonu- 
cleotides together. Incubation was allowed to continue at 37°C. Four- 
microliter aliquots of the reaction mixtures were withdrawn at various 
times ubsequently and quenched by ethanol precipitation i the pres- 
ence of 2 pg of glycogen carrier. The resulting populations of RNAs 
and oligonucleotides were recovered by centrifugation; the pellets 
were washed with 700 ice.cold ethanol and then redi~solved in 6.2 
pl of H20. 
Primer extension arrest (PEA) [25,26] of cleaved or ~dncleaved full- 
length [3APP6o5 or ~APP?~t mRNA in the presence or absence of 10 
pM facilitator oligonucleotides was performed as described previously 
[15]. Two picomoles of primer was incubated with dach set of ribo- 
zyme reaction samples in 8 pl of 9 mM Tris-HCI/pH 7.0, 63 mM 
NaC! for I rain at 90°C. After slow cooling at roor~l temperature for 
10 min, 2 pl of 30 mM MgCla, 25 mM DTT and 3 pCi [a32p]dCTP 
(3000 Ci/mmol) was added. The resultant hybridization mixture in 
2.75 pl aliquots was added to 2.5 pl extension buffer (34 mM Tris- 
HCI pH 7.0, 50 mM NaCI, 5 mM DTT, 250 pM dATP, 250 pM 
dGTP, 250 pM ¢ITTP and 10 pM dCTP). The mixture was incubated 
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for 30 min at 42°C with 1.25 units of AMV reverse transcriptase. 
Subsequently, 1 ~tl of a chase solution (2 mM dATP, 2 mM dGTP, 
2 mM dTTP, 2 mM dCTP in extension buffer) was added and incu- 
bation continued for an additional 15 rain at 42°C. Reactions were 
stopped by adding 5 ial of 10 M urea, 0.3% xylene cyanole, 0.3% 
bromphenol b ue; the resulting samples were stored at -100°C until 
they were used. PEA products were resolved on 10% polyacrylamide 
(19:1 polyacrylamide/bisacrylamide) 7M urea sequencing gels and 
quantified by scanning densitometry [23]. 
3. Resul~s 
3.1. The [lAPP-133 ribozyme binding site is masked by 
substrate secondary structure 
We have previously shown that trans-acting hammerhead 
ribozymes targeted to the first naturally occurring cleavage 
site in [lAPP mRNA, codon 47, cleave both full-length and 
short forms of [lAPP RNA in vitro, and specifically reduce 
steady-state ~APP levels in vivo [13,15,20-22,27]. However, 
the rate of full-length RNA substrate cleavage was 25-fold 
less than that observed with kinetically well behaved short 
model RNA substrates [15,23]. Preliminary evidence suggested 
that this reduction might be caused by higher order RNA 
effects. To determine whether association of the core ribozyme 
RNA and ~APPo9~ or [IAPPTnl mRNA was hindered, the rate 
of substrate dissociation of the [5133 trans-acting ribozyme, 
Fig. 1, was examined by pulse-chase experiments using short 
and full length substrate competitor RNAs. Fig. 2 shows the 
results of a typical experiment. I  is quite clear from these data 
that excess unlabeled [5133 substrate RNA completely inhib- 
ited 32P-radiolabeled [5133 substrate cleavage. This indicates 
that substrate dissociation for this short RNA is fast relative 
to the cleavage step. In contrast, excess full-length ~APP751 
RNA was unable to effectively compete a2P-radiolabeled sub- 
strate cleavage. This result suggests that binding of the 32p. 
radiolabeled [1133 substrate to the core ribozyme is much 
stronger than that of the full-length substrate. Since both 
the short and full-length substrate RNAs contain identical 
ribozyme binding sites, the inability of the full-length form 
to con'tpete 32P-radiolabeled [5133 substrate RNA supports 
the hypothesis that the site is masked by higher order struc- 
ture. 
3.2. Mechanism of facilitator action in vitro 
Primer extension arrest (PEA) studies have shown that 
short "facilitator" antisense deoxyoligonucleotides targeted 
upstream of the ribozyme binding site, Table 1, enhanced 
the rate of ribozyme-mediated cleavage of full-length [3APPT~I 
mRNA but had no effect upon the cleavage of model sub- 
strate RNAs in vitro. The magnitude of this enhancement 
depended on both the length of the deoxyoligonucleotide 
1331 ~ 151 
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Fig. i. 13133 trans-acting hammerhead ribozyme composed of RNA 
substrate strands [5133, or [3APPT~I (not shown) and core ribozyme 
RNA, Rz133. Numbering is based upon the [3APP695 cDNA se- 
quence [33]. The arrow marks the site of substrate cleavage. 
and its position with respect o the Y end of the ribozyme 
[15]. We now demonstrate hat facilitator oligonucleotides li- 
cit their effect on trans-ribozyme cleavage by enhancing ribo- 
zyme core RNA binding to its target sequence. 
PEA of full-length [lAPPcr, l or [SAPPier, mRNA ribozyme 
cleavage reactions, in the presence and absence of facilitator 
oligonucleotides, was used to determine this. PEA relies on 
the fact that reverse transcription can be paused or stopped in 
structured regions of RNA, or at modified nucleotides, or at 
sites of RNA cleavage [[15] and references therein]. In the 
population of cleaved and uncleared forms of [lAPP mRNA 
that exist in a typical ribozyme cleavage reaction a number of 
specific PEA products have been observed. Primer extension 
to the ribozyme cleavage site results in a 60 base labeled 
cDNA. If the sample contains uncleared [lAPP mRNA, a 
225 base labeled cDNA corresponding to extension to the 
end of the message is also observed [15]. In addition, a 74 
base labeled cDNA arising from extension to the 5' end of 
the facilitator oligonucleotide might be expected in reactions 
containing uncleared [lAPP mRNA, providing the facilitator 
oligonucleotide binds tightly enough at the extension tempera- 
ture (42°C). An experiment confirming this prediction is 
shown in Fig. 3A. At both 1 and 2 h, in the presence of 10 
~M [l112C or [l114C, specific arrests for the fnll-length mes- 
sage (not shown), the ribozyme cleaved message, and the fa- 
cilitator 5' end are observed (lanes 3 and 4); the latter arrest 
does not occur in the absence of the facilitators (lanes 1 and 
2). In parallel experiments using a mutationally inactive ribo- 
zyme RNA [15,20,22], [lll2C and 13114C were also found to 
produce full-length and facilitator-arrested cDNAs but, as 
expected, not the ribozyme cleavage site-arrested cDNA (not 
shown). The specificity of facilitator binding was further 
demonstrated in the experiment shown in Fig. 3B comparing 
Table 1 
Facilitator oligonucleotides 
Facilitator a Sequence Target region b
[~112C 5'ACACCGTCTGACTTGTAY 112-128 
[5114C 5'ACCGTCTGACTTGTAY 114-128 
[5 ! 16M 5'CGAGACTGATGTAY 116 -! 28 
[5116S 5'GCAGACTGAACATY 116-128 
[3112S 5'TGTGGCAGACTGAACATY 112-128 
[312 IC 5'GACTTGTACGTGTY 121-133 
aOligonucleotide nomenclature: [IXC=antisense facilitator oligonucleotide; I~XS -" sense strand oligonucleotid¢; ~XM =scrambled oligonucl¢o- 
tide. X refers to the position of the oligonucleotide relative to the 5' end of [~APP mRNA. 
bNumbering based on the start of the [SAPP mRNA coding sequence. 
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Fig, 2. [1133 substrate dissociation kinetics. "aP-radiolabeled [3133 
RNA's ability to di,ociate from Rz-133 RNA was analyzed by 
competition with excess unlabeled 13133 RNA (e), or unlabeled full 
length I~APPes: PNA (11) [15]. For comparison, a reaction in the 
abg, nce of competitor RNA (•)  is also shown. 
PEA products in the presence of 13112C and 13121C. Here, the 
5 base difference between facilitator binding sites is clearly 
observed. Additional arrests corresponding to extension 
from each facilitator oligonucleotide to the end of uncleared 
[LAPP mRNA are also observed. 
A 49 base eDNA was also observed in the presence of either 
1~112C or ~114C, and ribozyme core RNA (or inactive ribo- 
zyme core RNA) Fig. 3A; interestingly, the site of this arrest 
coincides with the 5' end of the ribozyme core RNA. Since 
there are equal amounts of ribozyme RNA in reactions with 
and without he facilitator, the presence of an arrest only in 
reactions containing the ribozyme and the facilitators indicate 
that the facilitators are linked to its production. The simplest 
explanation of this is that facilitator binding to uncleared 
~APP mRNA enhances ribozyme RNA binding during pri- 
mer extension. This hypothesis i supported by the observa- 
tion that the intensities of the 49 base ribozyme-arrested 
eDNA are directly proportional to the intensities of the 5' 
facilitator arrested eDNA over this time period (compare 
lanes 3 and 4). in addition, 1~121C which enhanced 13APP 
mRNA cleavage 3-fold less than [ll l2C under these condi- 
tions also produced proportionately ess of the 49 base 
eDNA, Fig. 3C. Finally, neither a sense cognate of I~112C, 
6112S, or another sense oligonucleotide .8116S, or a scrambled 
oligonucleotide control, 15116M, that should hybridize poorly 
to I~APP mRNA under PEA conditions produced 5' facilita- 
tor or 5' ribozyme-arrested cDNAs, Table 2. 
Mother facilitator-enhanced arrest was also observed in 
Fig. 3A, lanes 3 and 4. This arrest occurs at G144 in [SAPP 
mRNA and, like the arrest at the ribozyme 5' end, its inten- 
sity depends on the length of the facilitator used. The rela- 
tively low concentration of radiolabeled CTP in the PEA 
assay results in hypersensitive G-pausing [25]. Nonetheless, 
the G144 arrest was significantly enhanced in the presence of 
the facilitator compared to Gt4s, G149 and G150. There are at 
least two explanations for this phenomenon. First, it is possi- 
ble that Gt44 represents an alternative ribozyme cleavage site. 
While this is not without precedent [28], its existence was not 
detected in model reactions where other novel cleavage sites 
were exposed [29]. A more likely scenario for the origin of this 
arrest is that it too arises from ~APP mRNAs that still have 
the ribozyme bound. Since arrests are comprised of both ki- 
netic pauses as well as absolute stops, it is plausible to believe 
that AMV reverse transcriptase might pause at this particular 
G located near the end of the 7 base ribozyme helix III. In 
contrast, unpaired G149 and Gls0, and G14s, near the begin- 
ning of ribozyme helix Ill, should be less susceptible to re- 
verse transcriptase pausing. Thus, these data also support he 
hypothesis that facilitator oligonucleotides nhance the asso- 
ciation of the ribozyme with ~APP mRNA. We conclude 
therefore, that facilitator oligonucleotides nhance ribozyme- 
mediated full-length RNA cleavage in vitro by unmasking the 
ribozyme binding site. 
4. Dlseuulon 
For therapeutic applications, trans.acting ribozymes must 
associate with a specific target mRNA to form a cleavage- 
competent structure. Higher order RNA interactions can 
have deleterious effects on the rate of ribozyme cleavage. In- 
deed, both viroids and virusoids have been shown to regulate 
c/s-cleavage in this manner. For example, the transition be- 
tween the native and autocatalytic conformers of peach latent 
mosaic viroid (PLMVd) is the rate-limiting step in ribozyme 
catalysis [30]. Similarly, additional sequences in helix II of the 
satellite RNA of barley yellow dwarf virus (sBYDV) form a 
thermodynamically favored pseudoknot hat inhibits self- 
cleavage [12]. Mutations that disrupt he pseudoknot increase 
Table 2 
PEA intensities in the presence and absence of 10 pM facilitator oligonucleotides 
Relative PEA intensity ~ 
Facilitator S izeb Homology b 3' Facilitator Cleavage site 5' Ribozyme 
- -  NA ~ NA 0 0.12 0 
~112C 17 17/17 ! 0.46 0.12 
~114C ! 5 ! 5115 0.36 0.28 0.05 
[$116M 13 7/13 0 0.18 0 
~116S 13 9/13 0 0.13 0 
~I12S _ 17 I0/17 0 0.14 0 
~PEA intensities were measured following 2 h cleavage reactions of full-length [3APP695 mRNA. The intensity of the [3112C 5' facilitator arrest 
was arbitrarily set to 1,0; all other values were normalized accordingly, The results are the mean values of 2-3 experiments for each oligonu- 
deot~, 
bHomoloi~ to ~JAPP~,~ or [~APP~t mRNA was determined using the FASTA algorithm from the Genetics Computer Group (GCG Inc., Madison, 
wD. 
~NA, not applkable, 
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12 34  12  3 4 UAGC 
Facilitator 5' end 
Cleavage Site 
Ribozyme 5' end 
A lhr Cleavage 2hr Cleavage 
123 456 
Full length ~APP 
112C Extension 
B 
112C 3' End 
Full length ~APP 
121C Extension 
~121C 3' End 
123  456 
c ~,,~, ; ~  Ribozyme 5' End 
Fig. 3. Primer extension arrest products arising from [tAPP751 mRNA cleavage reactions. (A) PEA of I and 2 h ~APP751 mRNA cleavage reac- 
tions in the absence of ribozyme (lane 1), in the presence of ribozyme (lane 2), in the presence of ribozyme and 10 ~tM 9112C (lane 3), and in 
the presence of ribozyme and 10 ~tM [5114C. The ~APP751 message, ribozyme core RNA, and facilitator oligonucleotide and their orientations 
are shown schematically on the' left-hand side of the figure. The eDNA arising from reverse transcription is depicted by the arrow. Note that 
slightly more sample was lo~,ded in the 2 h time point of sample 2 compared to the 1 h time point. (B) PEA of a 30=60 rain time course of 
PAPP751 mRNA cleavage in the presence of ribozyme and 10 ~tM 13112C (lanes !-3) and in the presence of ribozyme and 10 IxM ~121C (lares 
4-6). Time points taken at 30, 40 and 60 min, respectively, are shown. The doublet bands arising from extension to the 5' ends of [3112C and 
~121C are due to reverse transcriptase tuttering [25]. *, ~121C binding also produces a significant reverse transcriptase arrest within its binding 
sequence. (C) 5' Ribozyme binding site region of (B). 
120 R.B. Denman/FEBS Letters 382 (1996) 116-120 
self-cleavage s veral hundred fold but cause the satellite RNA 
to replicate poorly, indicating that rapid RNA cleavage is not 
essential for (sBYDV) replication [31]. 
Separation of ribozymes into trans-acting variants contain- 
ing a substrate strand and an enzymatic ore further com- 
pounds the effects of higher order RNA structure interactions 
because in these cases, both RNAs may fold into structures 
that inhibit self-cleavage [13,23,32]. The masking of a partic- 
ular ribozyme cleavage site via secondary structure interac- 
tions is especially problematic if the site represents an ideal 
target such as a disease-causing mutation [22]. The data pre- 
sented in Fig. 2 dearly show that codon 47 in 13APP mRNA is 
masked by higher order structure; therefore this site can be 
used as a model to explore strategies for enhancing ribozyme 
cleavage, 
Facilitator deoxyoligonucleotides have been shown to en- 
hance ribozyme cleavage in vitro [15017]. Theoretically, en- 
hancement could occur during Hbozyme/substrate ssociation, 
ribozyme/product dissociation or the chemical cleavage step. 
Previous work has delimited these possibilities to either asso- 
ciation or dissociation [16], In this study we employed facil- 
itator olignnuoleotides targeted upstream of a ribozyme de- 
signed to cleave 13APP mRNA at codon 47. The results, Fig. 
3A and Table 2, demonstrate for the first time that facilitator 
olignnucleotides nhance the ribozyme binding step of the 
reaction, The ability to affect substrate binding rather than 
product dissociation should make facilitator oligonucleotides 
generally useful for targeting potentially interesting Hbozyme 
cleavage sites that are masked by higher order RNA structure 
in vivo. 
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